Some Washington policymakers with financial stakes in UnitedHealth Group are selling their stocks in the company as it struggles financially and the Trump administration investigates its billing ...

Now, it’s worth noting Stock Advisor’s total average return is 1,055% — a market-crushing outperformance compared to 183 % ...

UnitedHealth Group (UNH) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

Gilead Sciences (NASDAQ:GILD) stock fell 2.7% in pre-market trading Thursday after reports that CVS Health (NYSE:CVS) will not add the company’s new HIV prevention drug, Yeztugo, to its commercial ...

Berkshire's $1.57B stake in UnitedHealth lifted shares by 12%, sparking interest in UNH-heavy healthcare ETFs like IHF, TMED, XLV and MEDI.

CVS Health (CVS) won't include Gilead's (GILD) new HIV drug Yeztugo in its commercial healthcare plans, due to clinical, regulatory and financial factors. Read more here.

Palantir's stock has been on a downward trajectory since it peaked on August 12, falling more than 15% and marking it as the worst-performing stock in the S&P 500 during this period. Investors are ...

UnitedHealth Group Incorporated is expanding its healthcare horizons, focusing on home-based care through its Optum division. The move aims to make patient care more comfortable and cost-effective.

Leverage Shares 2X Long UNH Daily ETF offers leveraged exposure to UnitedHealth's stock via derivative positions with mild basis risk. See why UNHG is a Buy.

Renaissance Technologies is often referred to as the most successful hedge fund of all time. From 1998 to 2021, the firm’s Medallion Fund generated annualized after-fees returns of 39%. Despite ...

UnitedHealth (NYSE:UNH) stock grabbed headlines last week, as Warren Buffett – the legendary Oracle of Omaha – disclosed a $1 ...

Berkshire also revealed three “mystery stocks” in which it had been building positions in 2025: D.R. Horton DHI, Lennar LEN, and Nucor NUE. “Berkshire received permission from the SEC to keep these ...